These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

481 related items for PubMed ID: 20210074

  • 1. Organic solvents in the pharmaceutical industry.
    Grodowska K, Parczewski A.
    Acta Pol Pharm; 2010; 67(1):3-12. PubMed ID: 20210074
    [Abstract] [Full Text] [Related]

  • 2. Analytical methods for residual solvents determination in pharmaceutical products.
    Grodowska K, Parczewski A.
    Acta Pol Pharm; 2010; 67(1):13-26. PubMed ID: 20210075
    [Abstract] [Full Text] [Related]

  • 3. Separation processes for organic molecules using SCF Technologies.
    Daintree LS, Kordikowski A, York P.
    Adv Drug Deliv Rev; 2008 Feb 14; 60(3):351-72. PubMed ID: 18006179
    [Abstract] [Full Text] [Related]

  • 4. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G, Cain YT, Cooney C, Garcia T, Bizjak TG, Holte O, Jagota N, Komas B, Korakianiti E, Kourti D, Madurawe R, Morefield E, Montgomery F, Nasr M, Randolph W, Robert JL, Rudd D, Zezza D.
    J Pharm Sci; 2015 Mar 14; 104(3):803-12. PubMed ID: 25830179
    [Abstract] [Full Text] [Related]

  • 5. Drug safety and efficacy impaired by quality failure.
    Ekiert RJ.
    Pharmazie; 2011 Jun 14; 66(6):467-9. PubMed ID: 21699091
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of the chemical compatibility of plastic contact materials and pharmaceutical products; safety considerations related to extractables and leachables.
    Jenke D.
    J Pharm Sci; 2007 Oct 14; 96(10):2566-81. PubMed ID: 17701994
    [Abstract] [Full Text] [Related]

  • 7. Active pharmaceutical ingredient (API) production involving continuous processes--a process system engineering (PSE)-assisted design framework.
    Cervera-Padrell AE, Skovby T, Kiil S, Gani R, Gernaey KV.
    Eur J Pharm Biopharm; 2012 Oct 14; 82(2):437-56. PubMed ID: 22820647
    [Abstract] [Full Text] [Related]

  • 8. Risk reduction in biotherapeutic products.
    Ill CR, Dehghani H.
    Curr Opin Drug Discov Devel; 2009 Mar 14; 12(2):296-304. PubMed ID: 19333875
    [Abstract] [Full Text] [Related]

  • 9. A generic static headspace gas chromatography method for determination of residual solvents in drug substance.
    Cheng C, Liu S, Mueller BJ, Yan Z.
    J Chromatogr A; 2010 Oct 08; 1217(41):6413-21. PubMed ID: 20801455
    [Abstract] [Full Text] [Related]

  • 10. [Pharmaceutical product quality control and good manufacturing practices].
    Hiyama Y.
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010 Oct 08; (128):1-16. PubMed ID: 21381389
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of the European Pharmacopoeia method for control of residual solvents in some antibiotics.
    Sitaramaraju Y, Riadi A, D'Autry W, Wolfs K, Hoogmartens J, Van Schepdael A, Adams E.
    J Pharm Biomed Anal; 2008 Sep 10; 48(1):113-9. PubMed ID: 18584990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T, Dubina H, Fillipi G, Guidat R, Patnaik S, Poechlauer P, Shering P, Guinn M, Mcdonnell P, Johnston C.
    J Pharm Sci; 2015 Mar 10; 104(3):821-31. PubMed ID: 25448273
    [Abstract] [Full Text] [Related]

  • 15. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A, Pieters L, Apers S.
    Planta Med; 2009 Jun 10; 75(7):683-8. PubMed ID: 19204891
    [Abstract] [Full Text] [Related]

  • 16. Residual solvent analysis in hydrochloride salts of active pharmaceutical ingredients.
    Puranik SB, Pawar VR, Lalitha N, Pai PN, Rao GK.
    Pak J Pharm Sci; 2009 Oct 10; 22(4):410-4. PubMed ID: 19783521
    [Abstract] [Full Text] [Related]

  • 17. Improving drug manufacturing with process analytical technology.
    Rodrigues LO, Alves TP, Cardoso JP, Menezes JC.
    IDrugs; 2006 Jan 10; 9(1):44-8. PubMed ID: 16374733
    [Abstract] [Full Text] [Related]

  • 18. Overall impact of the regulatory requirements for genotoxic impurities on the drug development process.
    Giordani A, Kobel W, Gally HU.
    Eur J Pharm Sci; 2011 May 18; 43(1-2):1-15. PubMed ID: 21420491
    [Abstract] [Full Text] [Related]

  • 19. Total organic carbon (VCSN and VWP) and HPLC analysis for cleaning validation in a pharmaceutical pilot plant.
    Queralt M, García-Montoya E, Pérez-Lozano P, Suñé-Negre JM, Miñarro M, Ticó JR.
    PDA J Pharm Sci Technol; 2009 May 18; 63(1):42-57. PubMed ID: 19455941
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.